Back
Avidity Biosciences Vs. Entrada Therapeutics Industry Stock Comparison
Sell
13
RNA
Avidity Biosciences
Last Price:
$31.84
Seasonality Move:
38.33%
Sell
37
TRDA
Entrada Therapeutics
Last Price:
$17.60
Seasonality Move:
-24.47%
Sell
13
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
-
The current Avidity Biosciences [RNA] share price is $31.82. The Score for RNA is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
-
RNA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
37
Entrada Therapeutics (TRDA)
is a Sell
Is Entrada Therapeutics a Buy, Sell or Hold?
-
The current Entrada Therapeutics [TRDA] share price is $17.60. The Score for TRDA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
TRDA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $31.82Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing slight buying pressure.
TRDA Stock Price Chart
What is Entrada Therapeutics's stock price today?
-
The Entrada Therapeutics share price today is $17.60Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TRDA is experiencing slight buying pressure.
RNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.35 | Sell |
Relative Strength Index (14 RSI): | 31.67 | Sell |
Chaikin Money Flow: | 247445 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.75 - 42.97) | Sell |
Bollinger Bands (100): | (38.89 - 47.21) | Sell |
TRDA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.27 | Sell |
Relative Strength Index (14 RSI): | 41.98 | Sell |
Chaikin Money Flow: | 106552 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.67 - 20.29) | Sell |
Bollinger Bands (100): | (15.2 - 18.88) | Buy |
RNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.7 | Sell |
20-day SMA: | 37.3 | Sell |
50-day SMA: | 42.36 | Sell |
200-day SMA: | 37.02 | Sell |
8-day EMA: | 32.94 | Sell |
20-day EMA: | 36.33 | Sell |
50-day EMA: | 40.15 | Sell |
200-day EMA: | 36.08 | Sell |
TRDA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.02 | Sell |
20-day SMA: | 19.27 | Sell |
50-day SMA: | 18.48 | Sell |
200-day SMA: | 15.77 | Buy |
8-day EMA: | 18.11 | Sell |
20-day EMA: | 18.7 | Sell |
50-day EMA: | 18.33 | Sell |
200-day EMA: | 16.47 | Buy |
Avidity Biosciences Earnings Growth & RNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.26 per share.
Entrada Therapeutics Earnings Growth & TRDA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.13 per share, and a decrease next year of $4.09 per share.
Avidity Biosciences Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Entrada Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |